Pancreatic cancer tumor microenvironment is a major therapeutic barrier and target

Pancreatic cancer tumor microenvironment is a major therapeutic barrier and target

Pancreatic Ductal Adenocarcinoma (PDAC) is projected to become the 2nd leading cause of cancer-related deaths in the United States. Limitations in early detection and treatment barriers contribute to the lack of substantial success in the treatment of this challenging-to-treat malignancy. Desmoplasi...

Full description

Bibliographic Details
Main Authors:	Conner Hartupee, Bolni Marius Nagalo, Chiswili Y. Chabu, Mulu Z. Tesfay, Joycelynn Coleman-Barnett, John T. West, Omeed Moaven
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-02-01
Series:	Frontiers in Immunology
Subjects:	pancreatic adenocarcinoma tumor microenvironment PDAC TME tumor immune microenvironment immune therapeutics cancer immunology
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1287459/full

Similar Items

High hypoxia status in pancreatic cancer is associated with multiple hallmarks of an immunosuppressive tumor microenvironment
by: Hassan Sadozai, et al.
Published: (2024-03-01)

Tumor Microenvironment Role in Pancreatic Cancer Stem Cells
by: Aaron Galindo-Vega, et al.
Published: (2023-06-01)

KLF4: a multifunctional nexus connecting tumor progression and immune regulation
by: Yunjie Ju, et al.
Published: (2025-02-01)

Editorial: Tumor microenvironment immunophenotypes and disease progression
by: Ana Carolina Monteiro, et al.
Published: (2023-01-01)

Unveiling the immunosuppressive landscape of pancreatic ductal adenocarcinoma: implications for innovative immunotherapy strategies
by: Songyu Guo, et al.
Published: (2024-03-01)

Innate immune cells: Key players of orchestra in modulating tumor microenvironment (TME)
by: Mahvash Sadeghi, et al.
Published: (2024-03-01)

Editorial: Tumour microenvironment in cancer research and drug discovery
by: Nur Akmarina B. M. Said, et al.
Published: (2024-05-01)

Exosomes as mediators of tumor immune escape and immunotherapy in hepatocellular carcinoma
by: Ming-Cheng Guan, et al.
Published: (2022-09-01)

The role of RNA methylation in tumor immunity and its potential in immunotherapy
by: Yan Li, et al.
Published: (2024-06-01)

Editorial: Cell network in antitumor immunity of pediatric and adult solid tumors
by: Silvia Pesce, et al.
Published: (2023-07-01)

Multiple influence of immune cells in the bone metastatic cancer microenvironment on tumors
by: Shixin Chen, et al.
Published: (2024-02-01)

Tumor immune microenvironment (TIME) to enhance antitumor immunity
by: Sajin Rajbhandary, et al.
Published: (2023-05-01)

Spatial heterogeneity of infiltrating immune cells in the tumor microenvironment of non-small cell lung cancer
by: Xinyue Liu, et al.
Published: (2024-12-01)

Immunohistochemical Evaluation of the Tumor Immune Microenvironment in Pancreatic Ductal Adenocarcinoma
by: Gelu Mihai Breaza, et al.
Published: (2025-03-01)

Delineating spatial cell-cell interactions in the solid tumour microenvironment through the lens of highly multiplexed imaging
by: David E. Cohn, et al.
Published: (2023-10-01)

Tumor heterogeneity: preclinical models, emerging technologies, and future applications
by: Marco Proietto, et al.
Published: (2023-04-01)

From tumor microenvironment to emerging biomarkers: the reshaping of the esophageal squamous cell carcinoma tumor microenvironment by neoadjuvant chemotherapy combined with immunotherapy
by: Zhengzhou Qiu, et al.
Published: (2024-12-01)

The role of the microenvironment in tumor growth and spreading
by: V. О. Bitsadze, et al.
Published: (2024-03-01)

Intratumoral microbiota of pancreatic ductal adenocarcinoma impact patient prognosis by influencing tumor microenvironment
by: Jingze Leng, et al.
Published: (2024-09-01)

Exosome-mediated communication between gastric cancer cells and macrophages: implications for tumor microenvironment
by: Yue Qiu, et al.
Published: (2024-02-01)

Digital quantitative tissue image analysis of hypoxia in resected pancreatic ductal adenocarcinomas
by: Iram Siddiqui, et al.
Published: (2022-08-01)

Glycolysis-cholesterol metabolic axis in immuno-oncology microenvironment: emerging role in immune cells and immunosuppressive signaling
by: Jing Jin, et al.
Published: (2023-10-01)

Comparative profiling of single-cell transcriptome reveals heterogeneity of tumor microenvironment between solid and acinar lung adenocarcinoma
by: Dianke Li, et al.
Published: (2022-09-01)

Investigating the tumor-immune microenvironment through extracellular vesicles from frozen patient biopsies and 3D cultures
by: Ala’a Al Hrout, et al.
Published: (2023-05-01)

Innate and adaptive immune-directed tumour microenvironment in pancreatic ductal adenocarcinoma
by: Ann Mary Joseph, et al.
Published: (2024-02-01)

Whole-body bioluminescence imaging of T-cell response in PDAC models
by: Roisin McMorrow, et al.
Published: (2023-07-01)

Research progress on the mechanisms of tumor immune microenvironment and therapeutic interactions
by: Chen Dongping, et al.
Published: (2024-06-01)

Editorial: Molecular targeting of the tumor microenvironment for therapeutics in cancer metastasis
by: Subramanyam Dasari, et al.
Published: (2023-03-01)

SUMOylation patterns and signature characterize the tumor microenvironment and predict prognosis in lung adenocarcinoma
by: Zhike Chen, et al.
Published: (2023-04-01)

The (Sialyl) Tn antigen: Contributions to immunosuppression in gastrointestinal cancers
by: Christabelle Rajesh, et al.
Published: (2023-01-01)

Expression and clinical significance of NLRC5 in hepatocellular carcinoma
by: Xiangyu Ma, et al.
Published: (2024-12-01)

Exploring the synergy between tumor microenvironment modulation and STING agonists in cancer immunotherapy
by: Xiaoyan Qi, et al.
Published: (2024-12-01)

Viral Transcript and Tumor Immune Microenvironment-Based Transcriptomic Profiling of HPV-Associated Head and Neck Squamous Cell Carcinoma Identifies Subtypes Associated with Prognosis
by: Anastasiia Nikitina, et al.
Published: (2024-12-01)

LSD1: an emerging face in altering the tumor microenvironment and enhancing immune checkpoint therapy
by: M A A Mamun, et al.
Published: (2023-07-01)

Editorial: Tumor microenvironment and metabolic reprogramming in cancer
by: Xiaoling Cui, et al.
Published: (2024-10-01)

Tumor immune microenvironment in therapy‐naive esophageal adenocarcinoma could predict the nodal status
by: Andromachi Kotsafti, et al.
Published: (2023-03-01)

Immunovirotherapy Based on Recombinant Vesicular Stomatitis Virus: Where Are We?
by: Yuguo Zhang, et al.
Published: (2022-06-01)

M6A-Related Long Non-Coding RNA Displays Utility in Predicting Prognosis, Portraying the Tumor Immune Microenvironment and Guiding Immunotherapy in Pancreatic Ductal Adenocarcinoma
by: Guangyu Xu, et al.
Published: (2023-02-01)

Editorial: Modulation of T-cell function and survival by the tumor microenvironment
by: Kristian M. Hargadon, et al.
Published: (2023-08-01)

Neurotransmitters: promising immune modulators in the tumor microenvironment
by: Luxi Xiao, et al.
Published: (2023-05-01)